Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration
Identifieur interne : 000397 ( Istex/Checkpoint ); précédent : 000396; suivant : 000398Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration
Auteurs : M. Olivier [France] ; A. Petitjean [France] ; J. Teague [Royaume-Uni] ; S. Forbes [Royaume-Uni] ; J. K. Dunnick [États-Unis] ; J. T. Den Dunnen [Pays-Bas] ; A. Langer D [Norvège] ; J. M. Wilkinson [Royaume-Uni] ; M. Vihinen [Finlande, Australie] ; R. G. H. Cotton [Finlande] ; P. Hainaut [France]Source :
- Human Mutation [ 1059-7794 ] ; 2009-03.
English descriptors
Abstract
There are currently less than 40 locus‐specific databases (LSDBs) and one large general database that curate data on somatic mutations in human cancer genes. These databases have different scope and use different annotation standards and database systems, resulting in duplicated efforts in data curation, and making it difficult for users to find clear and consistent information. As data related to somatic mutations are generated at an increasing pace it is urgent to create a framework for improving the collecting of this information and making it more accessible to clinicians, scientists, and epidemiologists to facilitate research on biomarkers. Here we propose a data flow for improving the connectivity between existing databases and we provide practical guidelines for data reporting, database contents, and annotation standards. These proposals are based on common standards recommended by the Human Genome Variation Society (HGVS) with additions related to specific requirements of somatic mutations in cancer. Indeed, somatic mutations may be used in molecular pathology and clinical studies to characterize tumor types, help treatment choice, predict response to treatment and patient outcome, or in epidemiological studies as markers for tumor etiology or exposure assessment. Thus, specific annotations are required to cover these diverse research topics. This initiative is meant to promote collaboration and discussion on these issues and the development of adequate resources that would avoid the loss of extremely valuable information generated by years of basic and clinical research. Hum Mutat 0,1–8, 2008. © 2008 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/humu.20832
Affiliations:
- Australie, Finlande, France, Norvège, Pays-Bas, Royaume-Uni, États-Unis
- Angleterre, Caroline du Nord, Grand Londres, Hollande-Méridionale
- Leyde, Londres, Lyon
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration</title>
<author><name sortKey="Olivier, M" sort="Olivier, M" uniqKey="Olivier M" first="M." last="Olivier">M. Olivier</name>
</author>
<author><name sortKey="Petitjean, A" sort="Petitjean, A" uniqKey="Petitjean A" first="A." last="Petitjean">A. Petitjean</name>
</author>
<author><name sortKey="Teague, J" sort="Teague, J" uniqKey="Teague J" first="J." last="Teague">J. Teague</name>
</author>
<author><name sortKey="Forbes, S" sort="Forbes, S" uniqKey="Forbes S" first="S." last="Forbes">S. Forbes</name>
</author>
<author><name sortKey="Dunnick, J K" sort="Dunnick, J K" uniqKey="Dunnick J" first="J. K." last="Dunnick">J. K. Dunnick</name>
</author>
<author><name sortKey="Den Dunnen, J T" sort="Den Dunnen, J T" uniqKey="Den Dunnen J" first="J. T." last="Den Dunnen">J. T. Den Dunnen</name>
</author>
<author><name sortKey="Langer D, A" sort="Langer D, A" uniqKey="Langer D A" first="A." last="Langer D">A. Langer D</name>
</author>
<author><name sortKey="Wilkinson, J M" sort="Wilkinson, J M" uniqKey="Wilkinson J" first="J. M." last="Wilkinson">J. M. Wilkinson</name>
</author>
<author><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name>
</author>
<author><name sortKey="Cotton, R G H" sort="Cotton, R G H" uniqKey="Cotton R" first="R. G. H." last="Cotton">R. G. H. Cotton</name>
</author>
<author><name sortKey="Hainaut, P" sort="Hainaut, P" uniqKey="Hainaut P" first="P." last="Hainaut">P. Hainaut</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/humu.20832</idno>
<idno type="url">https://api.istex.fr/document/2DE84FF813197D14C9BAAE2548E4B68B956C6D42/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000538</idno>
<idno type="wicri:Area/Istex/Curation">000538</idno>
<idno type="wicri:Area/Istex/Checkpoint">000397</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration</title>
<author><name sortKey="Olivier, M" sort="Olivier, M" uniqKey="Olivier M" first="M." last="Olivier">M. Olivier</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea>
<placeName><settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Petitjean, A" sort="Petitjean, A" uniqKey="Petitjean A" first="A." last="Petitjean">A. Petitjean</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea>
<placeName><settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Teague, J" sort="Teague, J" uniqKey="Teague J" first="J." last="Teague">J. Teague</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Forbes, S" sort="Forbes, S" uniqKey="Forbes S" first="S." last="Forbes">S. Forbes</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dunnick, J K" sort="Dunnick, J K" uniqKey="Dunnick J" first="J. K." last="Dunnick">J. K. Dunnick</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Toxicology Operations Branch, National Institute of Environmental Health Sciences, Research Triangle Park</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Den Dunnen, J T" sort="Den Dunnen, J T" uniqKey="Den Dunnen J" first="J. T." last="Den Dunnen">J. T. Den Dunnen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Langer D, A" sort="Langer D, A" uniqKey="Langer D A" first="A." last="Langer D">A. Langer D</name>
<affiliation wicri:level="1"><country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Genetics, Institute for Cancer Research, Rikshospitalet‐Radiumhospitalet Medical Center, Oslo</wicri:regionArea>
<wicri:noRegion>Oslo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wilkinson, J M" sort="Wilkinson, J M" uniqKey="Wilkinson J" first="J. M." last="Wilkinson">J. M. Wilkinson</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Cancer Research Institute (NCRI) Cancer Informatics Initiative, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name>
<affiliation wicri:level="1"><country xml:lang="fr">Finlande</country>
<wicri:regionArea>Institute of Medical Technology, University of Tampere</wicri:regionArea>
<wicri:noRegion>University of Tampere</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Genomic Disorders Research Centre, St. Vincent's Hospital Melbourne, Melbourne</wicri:regionArea>
<wicri:noRegion>Melbourne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cotton, R G H" sort="Cotton, R G H" uniqKey="Cotton R" first="R. G. H." last="Cotton">R. G. H. Cotton</name>
<affiliation wicri:level="1"><country xml:lang="fr">Finlande</country>
<wicri:regionArea>Tampere University Hospital, Tampere</wicri:regionArea>
<wicri:noRegion>Tampere</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hainaut, P" sort="Hainaut, P" uniqKey="Hainaut P" first="P." last="Hainaut">P. Hainaut</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon</wicri:regionArea>
<placeName><settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Human Mutation</title>
<title level="j" type="abbrev">Hum. Mutat.</title>
<idno type="ISSN">1059-7794</idno>
<idno type="eISSN">1098-1004</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009-03">2009-03</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="275">275</biblScope>
<biblScope unit="page" to="282">282</biblScope>
</imprint>
<idno type="ISSN">1059-7794</idno>
</series>
<idno type="istex">2DE84FF813197D14C9BAAE2548E4B68B956C6D42</idno>
<idno type="DOI">10.1002/humu.20832</idno>
<idno type="ArticleID">HUMU20832</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1059-7794</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>somatic mutation; database; standards</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There are currently less than 40 locus‐specific databases (LSDBs) and one large general database that curate data on somatic mutations in human cancer genes. These databases have different scope and use different annotation standards and database systems, resulting in duplicated efforts in data curation, and making it difficult for users to find clear and consistent information. As data related to somatic mutations are generated at an increasing pace it is urgent to create a framework for improving the collecting of this information and making it more accessible to clinicians, scientists, and epidemiologists to facilitate research on biomarkers. Here we propose a data flow for improving the connectivity between existing databases and we provide practical guidelines for data reporting, database contents, and annotation standards. These proposals are based on common standards recommended by the Human Genome Variation Society (HGVS) with additions related to specific requirements of somatic mutations in cancer. Indeed, somatic mutations may be used in molecular pathology and clinical studies to characterize tumor types, help treatment choice, predict response to treatment and patient outcome, or in epidemiological studies as markers for tumor etiology or exposure assessment. Thus, specific annotations are required to cover these diverse research topics. This initiative is meant to promote collaboration and discussion on these issues and the development of adequate resources that would avoid the loss of extremely valuable information generated by years of basic and clinical research. Hum Mutat 0,1–8, 2008. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Finlande</li>
<li>France</li>
<li>Norvège</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Caroline du Nord</li>
<li>Grand Londres</li>
<li>Hollande-Méridionale</li>
</region>
<settlement><li>Leyde</li>
<li>Londres</li>
<li>Lyon</li>
</settlement>
</list>
<tree><country name="France"><noRegion><name sortKey="Olivier, M" sort="Olivier, M" uniqKey="Olivier M" first="M." last="Olivier">M. Olivier</name>
</noRegion>
<name sortKey="Hainaut, P" sort="Hainaut, P" uniqKey="Hainaut P" first="P." last="Hainaut">P. Hainaut</name>
<name sortKey="Petitjean, A" sort="Petitjean, A" uniqKey="Petitjean A" first="A." last="Petitjean">A. Petitjean</name>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Teague, J" sort="Teague, J" uniqKey="Teague J" first="J." last="Teague">J. Teague</name>
</noRegion>
<name sortKey="Forbes, S" sort="Forbes, S" uniqKey="Forbes S" first="S." last="Forbes">S. Forbes</name>
<name sortKey="Wilkinson, J M" sort="Wilkinson, J M" uniqKey="Wilkinson J" first="J. M." last="Wilkinson">J. M. Wilkinson</name>
</country>
<country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Dunnick, J K" sort="Dunnick, J K" uniqKey="Dunnick J" first="J. K." last="Dunnick">J. K. Dunnick</name>
</region>
</country>
<country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Den Dunnen, J T" sort="Den Dunnen, J T" uniqKey="Den Dunnen J" first="J. T." last="Den Dunnen">J. T. Den Dunnen</name>
</region>
</country>
<country name="Norvège"><noRegion><name sortKey="Langer D, A" sort="Langer D, A" uniqKey="Langer D A" first="A." last="Langer D">A. Langer D</name>
</noRegion>
</country>
<country name="Finlande"><noRegion><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name>
</noRegion>
<name sortKey="Cotton, R G H" sort="Cotton, R G H" uniqKey="Cotton R" first="R. G. H." last="Cotton">R. G. H. Cotton</name>
</country>
<country name="Australie"><noRegion><name sortKey="Vihinen, M" sort="Vihinen, M" uniqKey="Vihinen M" first="M." last="Vihinen">M. Vihinen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/CyberinfraV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000397 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000397 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= CyberinfraV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:2DE84FF813197D14C9BAAE2548E4B68B956C6D42 |texte= Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration }}
![]() | This area was generated with Dilib version V0.6.25. | ![]() |